RP
CRL icon

Riverwater Partners’s Charles River Laboratories CRL Stock Holding History

Riverwater Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,292
Closed -$1.6M – 213
2026
Q1 		$1.6M Buy
+9,292
New +$1.72M 0.53% 67
2024
Q4 		– Sell
-5,643
Closed -$1.09M – 219
2024
Q3 		$1.09M Buy
5,643
+126
+2% +$26.2K 0.54% 57
2024
Q2 		$1.14M Buy
5,517
+1,878
+52% +$426K 0.84% 27
2024
Q1 		$986K Buy
3,639
+32
+0.9% +$7.64K 0.72% 32
2023
Q4 		$853K Buy
3,607
+24
+0.7% +$4.72K 0.67% 40
2023
Q3 		$702K Sell
3,583
-42
-1% -$8.62K 0.64% 40
2023
Q2 		$762K Buy
3,625
+171
+5% +$34K 0.68% 42
2023
Q1 		$697K Buy
3,454
+19
+0.6% +$4.31K 0.64% 46
2022
Q4 		$748K Buy
3,435
+130
+4% +$28.4K 0.64% 41
2022
Q3 		$650K Buy
3,305
+1,232
+59% +$266K 0.65% 48
2022
Q2 		$444K Buy
2,073
+157
+8% +$38.4K 0.45% 69
2022
Q1 		$544K Sell
1,916
-1,900
-50% -$586K 0.9% 47
2021
Q4 		$1.44M Buy
+3,816
New +$1.48M 1.28% 10

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Riverwater Partners's CRL Position: Q2 2026 in Review

Riverwater Partners sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 9,292 shares — an estimated $1.6M sold.

Riverwater Partners first reported a position in CRL in Q4 2021 and held it in 13 quarters. The position peaked at $1.6M in Q1 2026. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Riverwater Partners reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Riverwater Partners sold 9,292 Charles River Laboratories shares in Q2 2026, an estimated $1.6M.
  • Riverwater Partners first reported a position in Charles River Laboratories in Q4 2021 and held it in 13 quarters.
  • Riverwater Partners's Charles River Laboratories position peaked at $1.6M in Q1 2026.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.